Lim; Hyung-Kwon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lim; Hyung-Kwon.The latest application filed is for "gene expression cassette for expressing n-terminal methionine-truncated protein of interest and method for producing n-terminal methionine-truncated protein of interest by using same".

Company Profile

6.9.13

Lim; Hyung-Kwon - Yongin-si KR
LIM; Hyung Kwon - Gyeonggi-do KR
Lim; Hyung-Kwon - Ithaca NY US
Lim; Hyung-Kwon - Gyunggi-do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-BCMA antibody having high affinity for BCMA and pharmaceutical composition for treatment of cancer, comprising same Grant 11,447,559 - Choi , et al. September 20, 2	2022-09-20
Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same Grant 11,401,343 - Kim , et al. August 2, 2	2022-08-02
Gene Expression Cassette For Expressing N-terminal Methionine-truncated Protein Of Interest And Method For Producing N-terminal Methionine-truncated Protein Of Interest By Using Same App 20220119792 - KIM; Jinhwan ; et al.	2022-04-21
Anti-mesothelin antibody and composition comprising the same Grant 10,851,175 - Kim , et al. December 1, 2	2020-12-01
Anti-cd3 Antibody And Pharmaceutical Composition For Cancer Treatment Comprising Same App 20200317779 - KIM; Ki Su ; et al.	2020-10-08
Anti-bcma Antibody Having High Affinity For Bcma And Pharmaceutical Composition For Treatment Of Cancer, Comprising Same App 20200299395 - CHOI; Hye-Ji ; et al.	2020-09-24
Anti-glypican 3 antibody and pharmaceutical composition containing the same Grant 10,752,697 - Park , et al. A	2020-08-25
Anti-msln Antibody And Pharmaceutical Composition For Cancer Treatment Comprising Same App 20200262928 - KIM; Ki Su ; et al.	2020-08-20
Antibody binding to TFPI and composition comprising the same Grant 10,266,607 - Kim , et al.	2019-04-23
Novel Anti-glypican 3 Antibody And Pharmaceutical Composition Containing The Same App 20180346592 - PARK; Jae Chan ; et al.	2018-12-06
Novel Anti-mesothelin Antibody And Composition Comprising The Same App 20180346588 - KIM; Dong-Sik ; et al.	2018-12-06
Screening and engineering method of super-stable immunoglobulin variable domains and their uses Grant 10,078,085 - Lim , et al. September 18, 2	2018-09-18
Novel Antibody Binding To Tfpi And Composition Comprising The Same App 20180030151 - KIM; Dong-Sik ; et al.	2018-02-01
Screening And Engineering Method Of Super-stable Immunoglobulin Variable Domains And Their Uses App 20160003844 - LIM; Hyung-Kwon ; et al.	2016-01-07
Engineering Correctly Folded Antibodies Using Inner Membrane Display Of Twin-arginine Translocation Intermediates App 20130045871 - DeLisa; Matthew ; et al.	2013-02-21
Methods for enhancing a secretion efficiency of recombinant foreign protein in yeast expression system Grant 8,298,787 - Lim , et al. October 30, 2	2012-10-30
Method For A Production Of A Recombinant Protein Using Yeast Co-expression System App 20110129872 - LIM; Hyung Kwon ; et al.	2011-06-02
Transformed Saccharomyces cerevisiae and method for mass-production of LK8 protein using the same Grant 7,858,361 - Lim , et al. December 28, 2	2010-12-28
Methods For Enhancing A Secretion Efficiency Of Recombinant Foreign Protein In Yeast Expression System App 20100184136 - Lim; Hyung-Kwon ; et al.	2010-07-22
Transformed Saccharomyces Cerevisiae and Method For Mass-Production of Lk8 Protein Using the Same App 20080187940 - Lim; Hyung-Kwon ; et al.	2008-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.